Gilead Sciences Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Revenue	29,442	28,754	27,116	27,281	27,305
Other Revenue	1	-	-	-	-
Revenue	29,443	28,754	27,116	27,281	27,305
Revenue Growth (YoY)	2.40%	6.04%	-0.60%	-0.09%	10.60%
Cost of Revenue	6,230	6,251	6,019	5,657	5,526
Gross Profit	23,213	22,503	21,097	21,624	21,779
Selling, General & Admin	5,709	6,000	6,062	5,673	5,246
Research & Development	5,687	5,816	5,758	4,977	4,601
Operating Expenses	11,396	11,816	11,820	10,650	9,847
Operating Income	11,817	10,687	9,277	10,974	11,932
Interest Expense	-1,024	-977	-944	-935	-1,001
Interest & Investment Income	-	281	376	106	-
Currency Exchange Gain (Loss)	-	14	-12	-	-23
Other Non Operating Income (Expenses)	347	-15	2	-30	-6
EBT Excluding Unusual Items	11,140	9,990	8,699	10,115	10,902
Merger & Restructuring Charges	-138	-189	-527	-	-
Gain (Loss) on Sale of Investments	451	-274	-167	-657	-610
Legal Settlements	-	-	-	-	-1,075
Other Unusual Items	-43	7	60	-	-
Pretax Income	9,796	691	6,860	5,814	8,278
Income Tax Expense	1,286	211	1,247	1,248	2,077
Earnings From Continuing Operations	8,510	480	5,613	4,566	6,201
Minority Interest in Earnings	-	-	52	26	24
Net Income	8,510	480	5,665	4,592	6,225
Net Income to Common	8,510	480	5,665	4,592	6,225
Net Income Growth	1672.92%	-91.53%	23.37%	-26.23%	4960.98%
Shares Outstanding (Basic)	1,244	1,247	1,248	1,255	1,256
Shares Outstanding (Diluted)	1,255	1,255	1,258	1,262	1,262
Shares Change (YoY)	-	-0.24%	-0.32%	-	-0.08%
EPS (Basic)	6.84	0.38	4.54	3.66	4.96
EPS (Diluted)	6.78	0.38	4.50	3.64	4.93
EPS Growth	1684.21%	-91.56%	23.63%	-26.17%	4938.22%
Free Cash Flow	9,456	10,305	7,421	8,344	10,805
Free Cash Flow Per Share	7.54	8.21	5.90	6.61	8.56
Dividend Per Share	3.160	3.080	3.000	2.920	2.840
Dividend Growth	2.60%	2.67%	2.74%	2.82%	4.41%
Gross Margin	78.84%	78.26%	77.80%	79.26%	79.76%
Operating Margin	40.13%	37.17%	34.21%	40.23%	43.70%
Profit Margin	28.90%	1.67%	20.89%	16.83%	22.80%
Free Cash Flow Margin	32.12%	35.84%	27.37%	30.59%	39.57%
EBITDA	14,581	13,454	11,970	13,077	13,982
EBITDA Margin	49.52%	46.79%	44.14%	47.93%	51.21%
D&A For EBITDA	2,764	2,767	2,693	2,103	2,050
EBIT	11,817	10,687	9,277	10,974	11,932
EBIT Margin	40.13%	37.17%	34.21%	40.23%	43.70%
Effective Tax Rate	13.13%	30.54%	18.18%	21.46%	25.09%
Revenue as Reported	29,443	28,754	27,116	27,281	27,305
Advertising Expenses	-	869	826	778	735

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q